Management to host conference call today at 4:30 p.m. ETLEXINGTON, Mass., March 19, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology ...
The Minister for Health, Dr. Noel Browne, was to the forefront in the fight against TB and established sanatoriums across the country, Creagh in Ballinrobe being the principal one in Mayo. Mayo County ...
Ray D’Arcy has officially returned to the airwaves with his new podcast, Ray D’Arcy Daily, just months after his departure ...
Legend Biotech (NASDAQ:LEGN) is one of the 17 biotechnology stocks with more than 50% upside. On January 20, Leonid Timashev of RBC Capital maintained an Outperform rating on Legend Biotech ...
CURE spoke with a provider and a survivor about the potential power of minimal residual disease testing. Minimal residual disease, or MRD, testing may have the potential to offer peace of mind to ...
After a short delay and concerns of potential intervention from senior officials, the FDA has issued a draft guidance for the industry on the potential use of minimal residual disease (MRD) and ...
New AI-derived model integrates longitudinal ctDNA and clinical data with digital pathology and tumor sequencing data, to refine recurrence risk assessment and outcomes prediction Natera, Inc. (NASDAQ ...
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the early access launch of Real-Time Variant Tracker, a powerful new option ...
Rochester, Minn.-based Mayo Clinic launched Mayo Clinic Platform_Orchestrate, a program aimed at helping biopharma and medical device companies accelerate clinical development. The program offers ...
Personalis has high upside potential if its MRD test gains Medicare reimbursement, but current revenue and margins are under pressure. The company faces declining pharma revenue, sustained cash burn, ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for identifying patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results